Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
OncoVista Innovative Therapies Inc (OVIT)
OTHER OTC:OVIT
OncoVista Innovative Therapies (OVIT) Stock Price & Analysis
4 Followers
OVIT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.3
Volume134.57K
Average Volume (3M)N/A
Market Cap
$2.36K
Enterprise Value$420.38K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Beta-25.24
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation20.20
R-Squared0.02
Alpha4.85
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.00%
Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
OVIT FAQ
What was OncoVista Innovative Therapies Inc’s price range in the past 12 months?
Currently, no data Available
What is OncoVista Innovative Therapies Inc’s market cap?
Currently, no data Available
When is OncoVista Innovative Therapies Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were OncoVista Innovative Therapies Inc’s earnings last quarter?
Currently, no data Available
Is OncoVista Innovative Therapies Inc overvalued?
According to Wall Street analysts OncoVista Innovative Therapies Inc’s price is currently Overvalued.
Does OncoVista Innovative Therapies Inc pay dividends?
OncoVista Innovative Therapies Inc does not currently pay dividends.
What is OncoVista Innovative Therapies Inc’s EPS estimate?
OncoVista Innovative Therapies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OncoVista Innovative Therapies Inc have?
OncoVista Innovative Therapies Inc has 23,559,000 shares outstanding.
What happened to OncoVista Innovative Therapies Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of OncoVista Innovative Therapies Inc?
Currently, no hedge funds are holding shares in OVIT
---
Company Description
OncoVista Innovative Therapies Inc
OncoVista Innovative Therapies, Inc. is a drug development company, which engages in the development and commercialization of targeted cancer therapies. The firm produces drug discovery, registration strategies, and emerging technologies. Its products include Cordycepin and L-Nucleoside Conjugate. The company was founded on January 8, 1999 and is headquartered in San Antonio, TX.
---
---